Anixa Biosciences (ANIX) EBITDA Margin Growth (5y) (2015 - 2023)
Powered by 
Analysis
Anixa Biosciences (ANIX) EBITDA Margin Growth (5y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.22 Bn | 9.38 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.06 Bn | 5.06 Bn | - |
| 3 | Iovance Biotherapeutics | 3.73 Bn | 3.43 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.61 Bn | 2.65 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.53 Bn | 2.53 Bn | - |
| 7 | Precigen | 2.37 Bn | 2.37 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.24 Bn | 1.44 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | Anixa Biosciences | 92.04 Mn | 92.04 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2023 | -103,225.00 |
| Oct 31, 2021 | 40.82 Mn |
| Jul 31, 2017 | -21,961.00 |
| Oct 31, 2016 | -23,237.00 |
| Jul 31, 2016 | -70,673.00 |
| Jul 31, 2015 | 61,979.00 |